Track insider transactions across markets
Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -9% | 8.2% | 15.1% |
| Success rate | 40% | 68% | 82% |
| Transactions |
5
20% Buy
|
34
71% Buy
|
47
69% Buy
|
| Average return | 5% |
|---|---|
| Success rate | 73% |
| Average holding period | 220 |
| Transactions | 28 |
| Position | Company | Period |
|---|---|---|
| Independent Director | Rhythm Pharmaceuticals Inc | April 1, 2015 - |
| Member of the Supervisory Board | Eurobio Scientific SA | Oct. 27, 2006 - |
| Special Advisor to the CEO | Ipsen SA | March 1, 2018 - Jan. 1, 2019 |
| Executive Vice President, Strategy Business Development | Ipsen SA | Jan. 1, 2016 - March 1, 2018 |
| Executive Vice President - Group Strategy and Business Development, Member of the Executive Committee | Ipsen SA | Oct. 2, 2013 - Jan. 1, 2016 |
| Executive Vice President - Operations and Member of the Executive Committee | Ipsen SA | None - |
Search
